Angiotech to host year-in-review presentation from 2004 Annual General Meeting of Shareholders
03 Juni 2004 - 11:05PM
PR Newswire (US)
Angiotech to host year-in-review presentation from 2004 Annual
General Meeting of Shareholders VANCOUVER, June 3
/PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:
ANPI; TSX: ANP), a specialty pharmaceutical company focusing on
drug-coated medical devices and biomaterials, will host a live
webcast of a year-in-review presentation to shareholders at its
annual general meeting on Thursday, June 10, 2004 beginning at 9:45
am PST (12:45 pm EST). The annual general meeting will be held at
Simon Fraser University's Center for Dialogue, in Vancouver, BC,
Canada. The presentation will be hosted by Dr. William Hunter,
President and Chief Executive Officer of Angiotech. The webcast
will be available to all interested parties through Angiotech's
website at http://www.angiotech.com/ under the Investor Relations
section and on a listen-only basis by dialing toll-free at
1-800-299-9630 and entering Access Code 88244642. To ensure a
timely connection to the webcast it is recommended that users
register approximately 15 minutes before the presentation. An audio
recording of the presentation will be available until June 17, 2004
by calling 1-888-286-8010 and entering Access Code 60646225.
Vancouver-based Angiotech Pharmaceuticals, Inc., a specialty
pharmaceutical company focusing on drug-coated medical devices and
biomaterials, is dedicated to enhancing the performance of medical
devices and biomaterials through the innovative uses of
pharmacotherapeutics. To find out more about Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPI)(TSE:ANP), please visit our
website at http://www.angiotech.com/. For more information contact:
Media: Eric Starkman Starkman & Associates (212) 252-8545
Analysts: Rui Avelar Angiotech Pharmaceuticals, Inc. (604) 221-7676
ext 6996 Investors: Ian Harper Angiotech Pharmaceuticals, Inc.
(604) 221-7676 ext 6933 DATASOURCE: Angiotech Pharmaceuticals, Inc.
CONTACT: Media: Eric Starkman, Starkman & Associates, (212)
252-8545; Analysts: Rui Avelar, Angiotech Pharmaceuticals, Inc.,
(604) 221-7676 ext 6996; Investors: Ian Harper, Angiotech
Pharmaceuticals, Inc., (604) 221-7676 ext 6933
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals (MM) News-Artikel